Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:17 PM
Ignite Modification Date:
2025-12-26 @ 1:17 PM
NCT ID:
NCT02279706
Eligibility Criteria:
Inclusion Criteria:
1. Adults over 19 years
2. Past medical history and allergy skin test or who have been diagnosed with allergic or non-allergic rhinitis, based on serum specific immunoglobulin E .
3. People who have experienced symptoms of rhinitis within 12 months from the time of study enrollment.
4. People who have rhinitis symptoms requiring medication at the time of study enrollment.
5. People who can read and write korea language.
6. People who signed a written consent form approved by the Institutional Review Board of their respective organizations to participate in this study freely hearing to explain fully the purpose for the contents of this study prior to participation in research.
Exclusion Criteria:
1. People diagnosed with Rhinitis medicamentosa.
2. People determined that bacterial or viral respiratory infection at the time of study enrollment.
3. People who have evidence of nasal infection
4. People associated anatomical abnormality that causes severe nasal congestion as deviation of nasal septum.
5. People determined that acute or chronic sinusitis according to the researchers determined.
6. In case that pregnancy test is positive, or ambiguous conclusions among female patients.
7. people deemed unsuitable for clinical trial participation due to other reasons.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT02279706
Study Brief:
Protocol Section:
NCT02279706